Channel Sponsor - Coding/Billing/Collections

Sponsored by National Medical Billing Services | info@nationalASCbilling.com | (636) 273-6711

HHS rules out negotiating with drug companies to lower prices — 3 insights

HHS Secretary Alex Azar ruled out the idea that Medicare could save money on drug prices by negotiating directly with drug companies, The Hill reports.

Here's what you should know.

1. While talking about the idea, Mr. Azar also said President Donald Trump could possibly go ahead and order negotiations with drug companies anyways.

2. Mr. Azar said President Trump wants to work to lower prices by merging drugs in Medicare's part B program with drugs in Medicare's part D program.

3. To accomplish that, legislators would have to pass a law. Mr. Azar said the idea could be explored in a demonstration project to begin with, but would eventually need a law before any widespread change could take place.

More articles on coding, billing and collections:
President Trump vows to 'bring soaring drug prices back down to earth' — 6 takeaways
4 new joint venture ASCs and partnerships — April/May 2018
Envision ponders sale & more — 9 ASC company key notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months